S&P 500
(-0.18%) 5 459.60 points
Dow Jones
(-0.12%) 39 064 points
Nasdaq
(0.07%) 17 731 points
Oil
(-0.21%) $80.66
Gas
(-3.74%) $2.65
Gold
(-0.71%) $2 314.30
Silver
(0.16%) $28.92
Platinum
(1.99%) $1 006.00
USD/EUR
(0.30%) $0.936
USD/NOK
(0.75%) $10.68
USD/GBP
(0.49%) $0.792
USD/RUB
(0.00%) $87.49

के लिए वास्तविक समय के अद्यतन Viking Therapeutics Inc [VKTX]

एक्सचेंज: NASDAQ क्षेत्र: Healthcare उद्योग: Biotechnology
BUY
37.50%
return -11.87%
SELL
37.50%
return -2.10%
अंतिम अद्यतन26 Jun 2024 @ 21:01

-1.67% $ 47.00

बेचें 34 min ago

@ $47.85

जारी किया गया: 26 Jun 2024 @ 20:26


वापसी: -1.78%


पिछला सिग्नल: Jun 24 - 19:02


पिछला सिग्नल: खरीदें


वापसी: -7.74 %

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 21:01):
Our systems believe the stock currently is undervalued by 0.10% compare to its pairs and should correct upwards.

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders...

Stats
आज की मात्रा 1.25M
औसत मात्रा 3.27M
बाजार मूल्य 5.18B
EPS $-0.260 ( Q1 | 2024-04-25 )
अगली कमाई की तारीख ( $-0.250 ) 2024-07-24
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -51.09
(Sector) 42.63
(Industry) 24.32
ATR14 $1.823 (3.88%)
AADI -2.94%
ABCL 1.65%
ABCM 0.04%
ABEO -2.84%
ABIO -1.68%
ABOS 1.64%
ABSI 2.55%
ABUS -2.30%
ABVX -3.53%
ACAD -0.64%
ACER -17.95%
ACET -4.75%
ACGN 1.29%
ACHL -3.00%
ACHV -1.61%
ACIU -1.00%
ACLX 0.17%
ACRV -4.79%
ACST -1.63%
ACXP 0.28%
ADAG 4.64%
ADAP -2.91%
ADGI 0.87%
ADIL 0.54%
ADMA -2.68%
ADPT -0.30%
ADTX -3.47%
ADVM -3.91%
ADXN -1.60%
AEON -3.74%
AEZS -3.51%
AFMD -1.40%
AGEN -1.82%
AGIO -2.10%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -3.12%
AKRO -2.85%
AKTX 4.08%
AKUS 0.00%
ALBO 0.00%
ALDX -2.40%
ALEC -2.29%
ALGS -2.41%
ALKS -0.19%
ALLK -8.55%
ALLO -6.23%
ALLR -3.22%
ALNA 3.16%
ALNY 1.85%
ALPN 0.02%
ALPX 0.00%
ALRN -0.33%
ALT -9.65%
ALVR -0.56%
ALXN 0.00%
ALXO -10.96%
ALZN 4.78%
AMRN -0.31%
AMTI -3.13%
ANAB 0.46%
ANEB -1.52%
ANGN 0.00%
ANIX -1.62%
ANL -6.60%
ANNX -0.66%
ANPC -3.15%
APGE -0.91%
APGN 8.48%
APGNW 30.65%
APLM 1.56%
APLS 0.09%
APLT -4.50%
APM -1.47%
APOP 0.38%
APRE 2.29%
APTO 3.27%
APTX 3.17%
APVO 0.18%
ARAV -13.39%
ARCT -3.90%
ARDS -14.23%
ARDX -0.66%
ARGX -0.73%
ARNA 0.00%
ARPO -0.90%
ARQT -0.52%
ARTL -2.50%
ARTLW 0.00%
ARVN 5.76%
ARWR -1.56%
ASLN -5.04%
ASMB -7.14%
ASND -0.94%
ATAI -1.48%
ATHA 5.94%
ATHE 1.12%
ATHX -33.50%
ATNF 0.99%
ATOS 3.40%
ATRA -3.45%
ATXI 1.93%
ATXS -0.61%
AUPH -1.17%
AURA 1.17%
AUTL -1.58%
AVBP -2.86%
AVEO 0.00%
AVIR -0.15%
AVRO -1.41%
AVTE -5.48%
AVTX -1.25%
AVXL -2.72%
AXLA 0.00%
AXSM -1.99%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 0.98%
BCAB 1.95%
BCDA -2.07%
BCDAW -41.77%
BCEL 0.00%
BCLI 7.14%
BCRX 1.32%
BCTX 7.65%
BCTXW -16.29%
BCYC 1.10%
BDRX -3.52%
BDTX -0.43%
BEAM 0.49%
BFRA -2.91%
BGNE -2.72%
BIOR -3.79%
BIVI 2.05%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -0.85%
BLTE -0.62%
BLU 0.03%
BLUE -0.52%
BMEA -9.88%
BMRN 0.41%
BNOX -2.22%
BNTC -2.11%
BNTX -1.46%
BOLD -8.11%
BOLT 1.31%
BPMC -1.21%
BPTH 1.86%
BPTS -13.47%
BRNS -0.74%
BRTX -2.36%
BTAI 22.98%
BTTX 53.33%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 3.39%
CABA 0.48%
CADL -1.42%
CALA 0.00%
CALC -1.77%
CALT -0.59%
CAPR -2.80%
CARA 0.21%
CARM 13.08%
CASI -1.67%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -6.16%
CCCC -5.22%
CCXI 0.00%
CDAK 0.00%
CDIO -2.02%
CDIOW 24.00%
CDMO -2.82%
CDMOP 0.04%
CDT -10.57%
CDTTW -39.60%
CDTX -1.92%
CDXC 0.00%
CDXS 6.07%
CELC -4.25%
CELU -1.50%
CELUW 11.80%
CERC -1.68%
CERE -0.89%
CERO -4.50%
CEROW -10.18%
CFRX -27.95%
CGEM -2.25%
CGEN -3.31%
CGON -0.54%
CGTX -5.11%
CHMA -6.00%
CHRS -0.63%
CINC 0.00%
CING 2.56%
CINGW 34.95%
CKPT -2.87%
CLBS -16.75%
CLDX -2.32%
CLGN 0.34%
CLLS -4.15%
CLNN 2.42%
CLNNW 0.00%
CLRB 7.04%
CLSD 1.02%
CLSN -0.68%
CLVS 0.00%
CMMB -0.01%
CMND 3.63%
CMPI 0.00%
CMPX -7.50%
CMRA 0.00%
CMRAW 33.33%
CMRX -2.71%
CNCE 0.00%
CNSP -39.30%
CNST 0.00%
CNTA -0.67%
CNTB -2.25%
CNTX -6.85%
COCP -2.02%
COEPW 32.45%
COGT -2.82%
CORT 2.20%
COYA -1.46%
CPRX -0.99%
CRBP -1.88%
CRBU -4.83%
CRDF -2.20%
CRGX 1.28%
CRIS -0.38%
CRNX -5.81%
CRSP 0.93%
CRTX 2.63%
CRVO -2.50%
CRVS 1.12%
CSBR -1.59%
CTCX -1.63%
CTIC 0.06%
CTMX -2.89%
CTNM -1.35%
CTXR 2.03%
CUE 3.53%
CVAC -2.26%
CVKD -5.23%
CWBR 2.80%
CYAD -12.96%
CYCC 10.09%
CYCCP 5.49%
CYCN 0.43%
CYT -2.27%
CYTK -1.89%
CYTO -2.73%
DARE 6.41%
DAWN 0.52%
DBTX -0.81%
DBVT 4.44%
DFFN 10.28%
DICE 0.06%
DMAC 34.01%
DNLI -1.43%
DNTH -6.35%
DOMH -1.58%
DRMA -1.10%
DRMAW -1.25%
DRNA 0.00%
DRTS 1.85%
DRTSW 0.00%
DRUG 0.95%
DSGN -1.21%
DTIL 0.31%
DYAI 9.68%
EARS -1.77%
EDIT -2.42%
EDSA -1.00%
EFTR 8.18%
EFTRW -51.85%
EIGR -9.21%
ELAB -1.00%
ELDN 7.98%
ELEV -4.98%
ELOX 7.69%
ELTX -0.88%
ELVN -4.05%
ELYM 1.67%
ENGN 1.67%
ENGNW 0.12%
ENLV 2.54%
ENOB 1.79%
ENSC 4.13%
ENTA -0.49%
ENTO -4.42%
ENTX 0.69%
ENVB 1.10%
EPIX -0.10%
EPRX -2.97%
EPZM 0.00%
EQ 0.86%
EQRX -2.09%
EQRXW 0.00%
ERAS -1.20%
ERNA 0.00%
ERYP 1.30%
ESLA 4.30%
ESLAW 87.05%
ETNB -1.02%
ETON 1.68%
ETTX 0.00%
EVAX -2.14%
EVGN 3.88%
EVLO 0.00%
EWTX 0.00%
EXAI -0.57%
EXEL -0.36%
EYEG -0.69%
EYEN 1.48%
EYPT -0.24%
FATE -7.66%
FBIO 0.59%
FBIOP 0.92%
FBLG -14.30%
FBRX -0.04%
FDMT -4.82%
FENC -0.97%
FGEN -5.13%
FHTX 2.10%
FIXX 0.77%
FMTX 0.00%
FNCH 8.87%
FOLD -2.58%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE -0.31%
FULC -3.34%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -6.28%
GANX -1.49%
GBIO -2.12%
GBT 0.01%
GDTC 0.50%
GERN -4.31%
GHRS -1.59%
GLMD -2.32%
GLPG -2.26%
GLSI 2.80%
GLTO -0.57%
GLUE -2.36%
GLYC -10.75%
GMAB -0.43%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -2.92%
GNLX 1.33%
GNPX 0.00%
GNTA 3.94%
GOSS -9.31%
GOVX 7.75%
GOVXW -49.04%
GPCR -6.51%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -0.08%
GRTX 0.00%
GTHX 0.45%
GUTS -5.31%
GXGXW 41.67%
GYRE -7.16%
HALO -1.15%
HARP 0.09%
HCWB -3.75%
HEPA 2.80%
HGEN -84.62%
HILS 5.66%
HLVX -0.57%
HOOK 0.80%
HOTH -2.70%
HOWL -2.14%
HRMY 0.85%
HRTX 2.62%
HSTO 0.00%
HUMA 0.91%
HUMAW -0.01%
IBRX -3.90%
ICCC 0.22%
ICPT 0.21%
ICU 16.49%
ICUCW 20.20%
ICVX -0.91%
IDRA -23.04%
IDYA -2.02%
IFRX -1.85%
IGMS -0.15%
IKNA 0.30%
IKT 1.42%
IMAB -0.58%
IMCR -2.62%
IMGN 0.02%
IMGO 0.00%
IMMP 4.55%
IMMX -6.90%
IMNM -1.65%
IMNN 0.88%
IMPL -27.27%
IMRA 15.96%
IMRN -1.18%
IMRX 0.00%
IMTX -1.50%
IMTXW 6.00%
IMUX 1.56%
IMV 0.00%
IMVT -3.63%
INAB 0.00%
INBX 0.53%
INCY -0.86%
INDP 11.07%
INFI -52.38%
INKT -0.01%
INM -2.20%
INMB 3.01%
INO -2.21%
INSM -0.89%
INTS -2.75%
INVA 0.22%
INZY 0.92%
IOBT -11.42%
IONS 0.40%
IOVA -2.31%
IPA 2.46%
IPHA 5.58%
IPSC -2.15%
IRON -2.54%
ISEE 0.38%
ITOS -1.50%
ITRM 1.67%
IVA 6.96%
IVVD -3.72%
JAGX 1.05%
JANX -4.03%
JAZZ -0.74%
JNCE 0.00%
JSPR -5.93%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -3.94%
KALV -1.95%
KDNY 0.22%
KMPH -0.34%
KNSA -2.85%
KNTE -0.38%
KOD -7.11%
KPRX 0.96%
KPTI -1.83%
KRBP -10.00%
KRON 1.05%
KROS -1.20%
KRRO -6.34%
KRTX 0.03%
KRYS -0.90%
KTRA 17.69%
KTTA 8.16%
KTTAW 0.92%
KURA -1.83%
KYMR -2.41%
KYTX -4.46%
KZIA 5.16%
KZR -1.49%
LABP 0.57%
LBPH -1.71%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.65%
LENZ -3.36%
LEXX 0.00%
LEXXW -14.63%
LGND -1.30%
LGNDV 0.00%
LGVN -9.61%
LIAN -8.28%
LIFE 2.70%
LIPO -7.10%
LIXT -5.24%
LIXTW 63.57%
LJPC -0.32%
LMNL 0.12%
LOGC 0.61%
LPCN -4.05%
LPTX -1.10%
LQDA -0.24%
LRMR -1.92%
LSTA -4.06%
LTRN 1.76%
LUMO -1.32%
LVTX 0.00%
LXEO -4.33%
LXRX -2.05%
LYEL -34.44%
LYRA 2.33%
MACK 0.10%
MBIO -9.32%
MBRX -1.72%
MCRB 2.29%
MDGL -2.70%
MDNA -13.16%
MDWD 0.10%
MDXG -2.58%
MEIP -0.13%
MESO -1.78%
MGNX -3.03%
MGTA -7.74%
MGTX -2.97%
MGX -2.68%
MIRM -1.80%
MIRO 0.59%
MIST 1.54%
MITO 0.00%
MLEC -7.69%
MLECW 2.31%
MLND -5.36%
MLTX -0.63%
MLYS -5.79%
MNKD -1.00%
MNMD 0.14%
MNOV 2.11%
MNPR -5.01%
MOLN 0.28%
MOR 1.29%
MORF -3.86%
MREO -4.72%
MRKR 2.68%
MRNA -4.91%
MRNS -4.04%
MRSN -2.62%
MRTX -0.17%
MRUS 0.13%
MRVI -1.82%
MTCR -1.29%
MTEM 4.46%
MTP -18.50%
MURA -1.24%
MYMD 8.38%
NAMS 1.37%
NAMSW 0.43%
NAUT 1.15%
NBRV 0.71%
NBSE -1.56%
NBTX 8.61%
NCNA 1.09%
NERV -1.90%
NEXI 2.60%
NGM -1.28%
NGNE -2.03%
NKGN 6.78%
NKGNW 8.00%
NKTR -4.21%
NKTX -4.57%
NLSP -2.82%
NLSPW 26.67%
NMRA -1.48%
NMTR -42.97%
NOVN -24.84%
NRBO 12.08%
NRIX -0.34%
NRSN -7.05%
NRSNW 0.00%
NRXP -4.09%
NRXPW 18.33%
NRXS 4.82%
NTBL 5.06%
NTEC -12.45%
NTHI 0.00%
NTLA -6.06%
NTRBW -31.07%
NUVL -2.00%
NVAX -2.21%
NVCT 3.59%
NVIV -34.28%
NXTC -2.94%
NYMX -0.05%
OABI 0.13%
OABIW -10.06%
OBIO -2.48%
OBSV 0.00%
OCEA 0.00%
OCGN 3.81%
OCS -1.02%
OCUL -2.21%
OCUP 1.96%
ODT -4.27%
OKYO 1.51%
OLMA -5.29%
OMER -1.28%
OMGA 5.00%
ONCO 5.04%
ONCR -3.08%
ONCS 31.87%
ONCT -1.87%
ONCY 0.99%
ONTX -0.47%
ONVO 0.99%
OPNT 0.00%
OPT 3.09%
ORGS -2.07%
ORIC -3.56%
ORMP 15.18%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -1.81%
OVID -1.44%
OYST 0.00%
PALI -0.87%
PASG -1.30%
PBLA -7.50%
PBM -6.75%
PBYI 1.69%
PCSA 0.00%
PCVX -0.37%
PDSB -2.52%
PEPG 0.27%
PGEN -2.99%
PHAR 1.51%
PHAS 0.00%
PHAT -1.06%
PHIO -3.57%
PHIOW 36.47%
PHVS -7.22%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -1.10%
PLUR 6.01%
PMN 0.72%
PMVP -1.19%
PNT 0.16%
PPBT -4.26%
PRAX 0.68%
PRDS 0.93%
PRLD 0.00%
PROG -3.47%
PROK 0.00%
PRQR -0.01%
PRTA -2.65%
PRTC 0.49%
PRTG -0.50%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -6.04%
PSTX -0.78%
PTCT -0.28%
PTE -0.82%
PTGX -1.76%
PTIXW -49.04%
PULM 2.60%
PXMD 0.00%
PYPD 0.07%
PYXS 1.96%
QLGN -6.61%
QNCX 5.70%
QNRX 0.37%
QSI -11.97%
QSIAW -3.13%
QTTB -4.54%
QURE -0.22%
RAIN -1.63%
RANI 6.42%
RAPT -2.92%
RARE 1.41%
RCKT -7.76%
REGN -0.70%
RENB -3.42%
REPL -2.61%
RETA 0.02%
REUN -0.89%
REVB -1.51%
REVBU 3.46%
REVBW 4.38%
RGLS -4.91%
RGNX -5.36%
RIGL -3.29%
RLAY -4.68%
RLMD 0.33%
RLYB 0.00%
RNA -0.56%
RNAC -4.80%
RNAZ -0.96%
RNXT 1.88%
ROIV -2.03%
ROIVW 4.56%
RPHM 0.00%
RPRX -0.07%
RPTX -2.64%
RUBY 2.70%
RVLP -32.05%
RVMD -1.20%
RVMDW -30.00%
RVNC 2.34%
RVPH -1.58%
RVPHW 1.62%
RXDX 0.09%
RXRX -3.20%
RYTM -6.51%
RYZB 0.02%
RZLT 1.68%
SABS -1.37%
SABSW -11.81%
SAGE 1.56%
SANA -3.87%
SAVA -0.31%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 5.50%
SCPH 0.00%
SCPS 0.00%
SEEL -4.48%
SEER 0.00%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -0.90%
SGMT -1.69%
SGTX -2.56%
SIOX 22.63%
SLDB -7.59%
SLGL 4.00%
SLN -4.21%
SLNO -4.03%
SLRX 6.04%
SLS -2.58%
SMMT -2.87%
SNDX 0.87%
SNGX -4.52%
SNPX -0.81%
SONN -1.08%
SPPI -0.49%
SPRB 0.32%
SPRC -4.17%
SPRO 0.30%
SRNE -34.00%
SRPT -1.14%
SRRA 0.00%
SRRK -2.79%
SRZN -2.45%
STAB 0.00%
STOK -5.29%
STRO -2.76%
STSA 0.00%
STTK -4.78%
SURF -0.93%
SVRA -3.29%
SWTX 0.34%
SYBX -1.94%
SYRS -1.72%
TALS -0.73%
TARA -7.57%
TARS -0.58%
TBPH 0.60%
TCBP 2.73%
TCDA 0.00%
TCON -1.35%
TCRR 0.00%
TCRT 1.59%
TCRX 2.83%
TECH -0.14%
TENX -1.27%
TERN -7.86%
TFFP -3.05%
TGTX -2.97%
THRX 0.12%
TIL -0.20%
TLC 0.00%
TLSA -3.09%
TNGX -2.16%
TNXP -6.39%
TNYA -7.02%
TPST 2.87%
TRDA -3.93%
TRVI 1.15%
TRVN 2.92%
TSHA -24.44%
TSVT -2.79%
TTNP -9.27%
TVTX 0.63%
TYRA -6.95%
UBX -2.12%
UNCY -2.43%
URGN -0.87%
UTHR -0.39%
VACC 11.36%
VALN -2.89%
VAXX 87.50%
VBIV 0.78%
VBLT -8.77%
VCEL 0.09%
VCNX 10.35%
VCYT -1.23%
VERA -2.55%
VERU 0.79%
VERV -2.96%
VIGL 5.11%
VINC 1.62%
VIR 0.54%
VIRI -1.57%
VIRX 2.40%
VKTX -1.67%
VLON -13.04%
VNDA -2.20%
VOR -2.02%
VRCA -0.07%
VRDN -4.31%
VRNA -1.33%
VRPX 0.38%
VRTX 0.39%
VSTM -3.58%
VTGN -0.45%
VTVT -2.97%
VTYX 0.00%
VXRT -2.88%
VYGR -1.53%
VYNE -3.47%
VYNT 7.78%
WINT -3.24%
WVE -4.51%
XBIO 0.93%
XBIT 1.77%
XCUR 3.58%
XENE -2.85%
XERS 2.38%
XFOR 2.62%
XLO 2.00%
XLRN 0.00%
XNCR 0.47%
XOMA -3.57%
XOMAO 0.36%
XOMAP -0.82%
XRTX -8.92%
YMAB -1.80%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -3.40%
ZNTL -2.38%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-05-03 Zante Greg Buy 30 000 Common Stock, par value $0.00001 per share
2024-05-03 Zante Greg Sell 3 101 Common Stock, par value $0.00001 per share
2024-05-03 Zante Greg Buy 4 249 Common Stock, par value $0.00001 per share
2024-05-03 Zante Greg Sell 45 570 Common Stock, par value $0.00001 per share
2024-05-03 Zante Greg Sell 17 238 Common Stock, par value $0.00001 per share
INSIDER POWER
0.84
Last 100 transactions
Buy: 2 816 709 | Sell: 2 831 066
सहसंबंध (AI algo v.1.1b): Undervalued: 0.10% $47.06 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

मात्रा सहसंबंध

लंबा: 0.22 (neutral)
छोटा: -0.92 (very strong negative)
Signal:(34) Neutral

Viking Therapeutics Inc सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
CDRO0.941
TXRH0.928
TRVI0.927
PLMR0.924
ADSE0.921
MEDP0.921
CLBT0.917
BCYC0.917
MACK0.914
LPLA0.912
10 सबसे अधिक नकारात्मक सहसंबंध
CYAN-0.954
RAPT-0.939
PENN-0.932
CAR-0.928
ROKU-0.925
AUPH-0.92
MFIN-0.919
SSRM-0.917
SABR-0.916
QDEL-0.914

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Viking Therapeutics Inc सहसंबंध - मुद्रा/वस्त्र

The country flag 0.12
( neutral )
The country flag 0.16
( neutral )
The country flag 0.00
( neutral )
The country flag 0.12
( neutral )
The country flag 0.00
( neutral )
The country flag -0.12
( neutral )

Viking Therapeutics Inc वित्तीय

Annual 2023
राजस्व: $0
सकल लाभ: $-292 000 (0.00 %)
EPS: $-0.910
FY 2023
राजस्व: $0
सकल लाभ: $-292 000 (0.00 %)
EPS: $-0.910
FY 2022
राजस्व: $0
सकल लाभ: $-291 000 (0.00 %)
EPS: $-0.880
FY 2021
राजस्व: $0.00
सकल लाभ: $0.00 (0.00 %)
EPS: $-0.757

Financial Reports:

No articles found.

Viking Therapeutics Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Viking Therapeutics Inc

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

के बारे में लाइव सिग्नल्स

इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।

लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं

Total Execution Time: 2.6960380077362 seconds
Number of API calls: 3
Number of DB calls: 9